Skip to main content

Table 3 Responses to treatment by HBsAg-positive and -negative DLBCL patients according to R-CHOP and CHOP regimens

From: Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China

Treatment response HBsAg-positive patients HBsAg-negative patients
R-CHOP (n = 60) CHOP (n = 66) P value R-CHOP (n = 143) CHOP (n = 150) P value
CR/CRu 42 36 0.082 114 82 0.001
PR 15 25   28 55  
SD 0 1   1 3  
PD 3 4   0 10  
  1. CHOP cyclophosphamide, doxorubicin, vincristine and prednisone, R-CHOP addition of rituximab to CHOP, CR complete response, PR partial response, SD stable disease, PD progressive disease